KR20180044706A - Method for preparing corn silk fermentation product enhanced gamma-aminobutyric acid contents - Google Patents
Method for preparing corn silk fermentation product enhanced gamma-aminobutyric acid contents Download PDFInfo
- Publication number
- KR20180044706A KR20180044706A KR1020160138537A KR20160138537A KR20180044706A KR 20180044706 A KR20180044706 A KR 20180044706A KR 1020160138537 A KR1020160138537 A KR 1020160138537A KR 20160138537 A KR20160138537 A KR 20160138537A KR 20180044706 A KR20180044706 A KR 20180044706A
- Authority
- KR
- South Korea
- Prior art keywords
- corn steep
- fermented
- gaba
- lab459
- corn
- Prior art date
Links
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 title claims abstract description 98
- 240000008042 Zea mays Species 0.000 title claims abstract description 74
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 title claims abstract description 49
- 229960003692 gamma aminobutyric acid Drugs 0.000 title claims abstract description 49
- 238000000855 fermentation Methods 0.000 title claims description 19
- 230000004151 fermentation Effects 0.000 title claims description 19
- 238000000034 method Methods 0.000 title claims description 18
- 235000007244 Zea mays Nutrition 0.000 title abstract 7
- 229940089639 cornsilk Drugs 0.000 title abstract 7
- 239000001231 zea mays silk Substances 0.000 title abstract 7
- 241000186660 Lactobacillus Species 0.000 claims abstract description 11
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 11
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 11
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 11
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 10
- 244000005700 microbiome Species 0.000 claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 67
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 67
- 235000005822 corn Nutrition 0.000 claims description 67
- 108020004465 16S ribosomal RNA Proteins 0.000 claims description 11
- 235000013376 functional food Nutrition 0.000 claims description 9
- 244000269722 Thea sinensis Species 0.000 claims description 7
- 235000013361 beverage Nutrition 0.000 claims description 6
- 235000009508 confectionery Nutrition 0.000 claims description 6
- 235000015110 jellies Nutrition 0.000 claims description 6
- 239000008274 jelly Substances 0.000 claims description 6
- 239000004922 lacquer Substances 0.000 claims description 3
- 238000012258 culturing Methods 0.000 abstract description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 26
- 239000004310 lactic acid Substances 0.000 description 13
- 235000014655 lactic acid Nutrition 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 102000006995 beta-Glucosidase Human genes 0.000 description 9
- 108010047754 beta-Glucosidase Proteins 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- 238000004809 thin layer chromatography Methods 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 235000013616 tea Nutrition 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000001766 physiological effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 3
- 235000016068 Berberis vulgaris Nutrition 0.000 description 3
- 241000335053 Beta vulgaris Species 0.000 description 3
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 3
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 3
- 229940093496 esculin Drugs 0.000 description 3
- 108010055793 gabase Proteins 0.000 description 3
- 238000013081 phylogenetic analysis Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000004451 qualitative analysis Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000030564 negative regulation of blood pressure Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- -1 pH adjusters Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/166—Addition of, or treatment with, enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/038—Gamma-amino butyric acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A23Y2220/67—
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 특이적인 유산균을 이용하여 감마-아미노뷰티르산(gamma-aminobutyric acid, GABA)을 다량 포함하는 옥수수수염의 발효물을 제조하는 방법에 관한 것이다.The present invention relates to a method for producing a fermented product of corn bean containing a large amount of gamma-aminobutyric acid (GABA) using specific lactic acid bacteria.
감마-아미노뷰티르산(γ-aminobutyric acid, GABA)은 인체의 중추신경계에서 신경전달에 관여하는 억제성 신경전달물질로서, 혈압상승을 억제하고 시력증진 효능이 있으며 불안감, 초조감 등을 진정시키는 작용을 하는 것으로 알려져 있다. Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter that is involved in neurotransmission in the central nervous system of the human body. It suppresses the increase of blood pressure, has the effect of improving the visual acuity and calms the anxiety and nervousness. .
또한, GABA는 동물의 뇌, 심장, 폐, 신장 등에 널리 분포되어 있으며, 스트레스에 시달리는 현대인이나 수험생, 알코올 과다 섭취자의 경우 뇌와 혈중에 GABA 농도가 낮은 것으로 보고되어 있고, 체내 GABA 농도의 부족은 발작, 경련, 간질 증세를 일으키는 것으로 알려져 있다.In addition, GABA is widely distributed in animal brain, heart, lung, and kidney. It is reported that GABA concentration in the brain and blood is low in modern people, examinees and alcohol-consuming people suffering from stress, Seizures, convulsions, and epilepsy.
상기와 같이 GABA의 기능성이 널리 알려지면서, GABA를 의약품으로서 뿐만 아니라 기능성 식품의 소재로 이를 섭취할 수 있는 방법에 대한 관심이 높아지고 있다. As described above, since the functionality of GABA is widely known, there is a growing interest in a method for ingesting GABA as a drug as well as a functional food material.
하지만, 상기한 GABA는 현미, 녹차, 맥아, 배추 등에 함유되어 있으나, 그 함량이 낮아 이를 포함하는 천연물 자체를 섭취하는 양만으로는 인체에 생리활성을 증진시키는 효과를 기대하기 어려워, GABA 함량을 증가시키는 방법에 대한 기술개발이 필요하다.However, the above-mentioned GABA is contained in brown rice, green tea, malt, cabbage and the like, but its content is low and it is difficult to expect the effect of increasing the physiological activity to the human body by only ingesting the natural product itself containing it. Technological development of methods is needed.
본 발명의 발명자들은 우수한 유산균에 대해 연구하던 중, β-글루코시다아제(β-glucosidase) 활성이 우수한 유산균을 이용하여 옥수수수염 추출물을 발효시키면 GABA 함량이 증진된 옥수수수염 발효물을 제조할 수 있다는 사실을 발견하였다.The inventors of the present invention have found that when fermenting a corn steep liquor with lactic acid bacteria having excellent β-glucosidase activity, it is possible to produce a fermented corn steep liquor having an increased GABA content I found the fact.
따라서, 본 발명은 특정 유산균으로 옥수수수염 추출물을 발효해 생리활성 물질인 GABA를 다량 포함하는 옥수수수염 발효물을 제조하는 방법에 관한 기술내용을 제공하는 것을 그 목적으로 한다.Accordingly, it is an object of the present invention to provide a technique for producing a fermented corn steep liquor containing a large amount of GABA, which is a physiologically active substance, by fermenting corn musth extract with a specific lactic acid bacterium.
상기한 바와 같은 기술적 과제를 달성하기 위해서 본 발명은, 락토바실러스(Lactobacillius)속 미생물을 옥수수수염 추출물에 접종한 후, 발효시켜 옥수수수염 발효물을 제조하는 단계를 포함하는 옥수수수염 발효물의 제조방법을 제공한다.To achieve these and other advantages and in accordance with the purpose of the present invention, as embodied and broadly described herein, there is provided a method for preparing a fermented corn steep lacquer, comprising the step of inoculating a microorganism belonging to the genus Lactobacillus into a corn steep liquor, to provide.
또한, 상기 락토바실러스(Lactobacillius)속 미생물은 서열번호 1로 표시되는 16s rRNA를 포함하는 락토바실러스 플란타럼 LAB459(Lactobacillus plantarum LAB459)인 것을 특징으로 한다.The microorganism belonging to the genus Lactobacillus is Lactobacillus plantarum LAB459 containing 16s rRNA represented by SEQ ID NO: 1.
또한, 상기 락토바실러스 플란타럼 LAB459를 옥수수수염 추출물에 접종한 후, 36 내지 72시간 동안 배양하는 것을 특징으로 한다.Further, the LAB459 is inoculated into the corn beard extract and then cultured for 36 to 72 hours.
또한, 상기 락토바실러스 플란타럼 LAB459을 접종하여 제조한 옥수수수염 발효물은 감마-아미노부티르산을 900 내지 1000 ppm/mL의 농도로 포함하는 것을 특징으로 한다.The corn steep liquor fermented product prepared by inoculating Lactobacillus plantarum LAB459 is characterized by containing gamma-aminobutyric acid at a concentration of 900 to 1000 ppm / mL.
또한, 본 발명은 상기에 기재된 방법을 이용해 제조한 옥수수수염 발효물을 포함하는 차, 젤리, 껌, 캔디 및 음료로 이루어진 군으로부터 선택되는 1종의 기능성 식품을 제공한다.The present invention also provides a functional food selected from the group consisting of tea, jelly, gum, candy, and beverages comprising the fermented corn steep state product prepared using the above-described method.
본 발명에 따른 옥수수수염 발효물의 제조방법에 따르면, 락토바실러스 플란타럼 LAB459을 옥수수수염 추출물에 접종 및 배양하여 감마-아미노부티르산의 함량이 높은 옥수수수염 발효물을 제조할 수 있다.According to the method for preparing the fermented corn steep liquor according to the present invention, the fermented corn steep liquor having a high gamma-aminobutyric acid content can be prepared by inoculating and culturing the LAB459 with LAB459.
상기와 같이 제조한 옥수수수염 발효물은 GABA의 함량이 높아 차, 젤리, 껌, 캔디 또는 음료 등과 같은 기능성 식품 제조에 활용이 가능하다.The fermented corn steep liquor prepared as described above has a high content of GABA, and thus can be used for the production of functional foods such as tea, jelly, gum, candy or beverage.
도 1은 실시예에 따른 유산균 균주를 분리하기 위한 에스쿨린 가수분해 분석 결과이다.
도 2는 실시예에 따른 유산균 균주의 계통수 분석 결과를 나타내는 계통도이다.
도 3은 실시예에 따른 방법으로 제조한 옥수수수염 발효물에 생성된 GABA를 검출하기 위한 (a) GABA의 표준물질 피크(280 nm) 및 (b) 발효물에 생성된 GABA의 검출 피크(358 nm)가 나타난 HPLC 분석 결과이다.
도 4는 실시예에 따른 방법으로 제조한 옥수수수염 발효물에 생성된 GABA를 정성분석하기 위한 TLC 분석 결과이다.FIG. 1 shows results of hydrolysis of Escherichia coli for isolating lactic acid bacteria strains according to the examples.
2 is a systematic diagram showing the results of the phylogenetic analysis of the lactic acid bacteria strain according to the embodiment.
Figure 3 shows the detection peaks of 358 (a) GABA standard peaks (280 nm) and (b) GABA produced in the fermentation to detect the GABA produced in the corn steep fermented product prepared by the method according to the example nm).
FIG. 4 is a TLC analysis result for the qualitative analysis of GABA produced in the corn steep liquor fermented by the method according to the example.
이하, 본 발명을 상세히 설명하도록 한다.Hereinafter, the present invention will be described in detail.
본 발명은, 락토바실러스(Lactobacillius)속 미생물을 옥수수수염 추출물에 접종한 후, 발효시켜 옥수수수염 발효물을 제조하는 단계를 포함하는 옥수수수염 발효물의 제조방법을 제공한다.The present invention provides a method for producing a fermented corn steep lacquer comprising the step of inoculating a microorganism belonging to the genus Lactobacillus into a corn bean extract, followed by fermentation to produce a corn steep ferment.
상기 옥수수수염 추출물은 옥수수수염을 열수 추출, 에탄올 추출 등의 통상적인 방법을 이용해 제조한 것을 사용할 수 있으며, 바람직하게는, 열수 추출 방법을 이용해 제조한 옥수수수염 열수 추출물을 사용할 수 있으며, 옥수수수염은 이물질을 제거한 일반 옥수수수염 또는 건조한 옥수수수염을 제한받지 않고 사용할 수 있다.The corn beard extract may be prepared by a conventional method such as hot water extraction or ethanol extraction, and preferably, a corn steep hot water extract prepared using a hot water extraction method may be used. You can use unrestricted common corn beets or dried corn beets without restriction.
일례로, 상기 열수 추출은 상기 옥수수수염을 2 중량%를 90 ℃ 이상으로 가열된 물에 첨가하여 30 내지 120분 이상 가열하는 방법으로 옥수수수염 열수 추출액을 제조하고, 제조한 열수 추출액을 여과 및 제균하여 제조한 옥수수수염 열수 추출물을 사용할 수 있다.For example, the hot water extraction is performed by adding 2 wt% of the corn beard to water heated to 90 DEG C or higher and heating the corn steep liquor for 30 to 120 minutes or longer to prepare a corn steep liquor hot water extract, A corn steep hot-water extract may be used.
상기 상기 락토바실러스(Lactobacillius)속 미생물은 하기의 서열번호 1로 표시되는 16s rRNA를 포함하는 락토바실러스 플란타럼 LAB459일 수 있다.The microorganism belonging to the genus Lactobacillus may be Lactobacillus plantarum LAB459 containing 16s rRNA represented by SEQ ID NO: 1 below.
[서열번호 1][SEQ ID NO: 1]
ggggggtaacgtgtcggattattgggcgtaagcgagcgcaggcggttttttaagtctgat 60gggggggtaacgtgtcggattattgggcgtaagcgagcgcaggcggttttttaagtctgat 60
gtgaaagccttcggctcaaccgaagaagtgcatcggaaactgggaaacttgagtgcagaa 120gtgaaagccttcggctcaaccgaagaagtgcatcggaaactgggaaacttgagtgcagaa 120
gaggacagtggaactccatgtgtagcggtgaaatgcgtagatatatggaagaacaccagt 180gaggacagtggaactccatgtgtagcggtgaaatgcgtagatatatggaagaacaccagt 180
ggcgaaggcggctgtctggtctgtaactgacgctgaggctcgaaagtatgggtagcaaac 240ggcgaaggcggctgtctggtctgtaactgacgctgaggctcgaaagtatgggtagcaaac 240
aggattagataccctggtagtccataccgtaaacgatgaatgctaagtgttggagggttt 300aggattagataccctggtagtccataccgtaaacgatgaatgctaagtgttggagggttt 300
ccgcccttcagtgctgcagctaacgcattaagcattccgcctggggagtacggccgcaag 360ccgcccttcagtgctgcagctaacgcattaagcattccgcctggggagtacggccgcaag 360
gctgaaactcaaaggaattgacgggggcccgcacaagcggtggagcatgtggtttaattc 420gctgaaactcaaaggaattgacgggggcccgcacaagcggtggagcatgtggtttaattc 420
gaagctacgcgaagaaccttaccaggtcttgacatactatgcaaatctaagagattagac 480gaagctacgcgaagaaccttaccaggtcttgacatactatgcaaatctaagagattagac 480
gttcccttcggggacatggatacaggtggtgcatggttgtcgtcagctcgtgtcgtgaga 540gttcccttcggggacatggatacaggtggtgcatggttgtcgtcagctcgtgtcgtgaga 540
tgttgggttaagtcccgcaacgagcgcaacccttattatcagttgccagcattaagttgg 600
gcactctggtgagactgccggtgacaaaccggaggaaggtggggatgacgtcaaatcatc 660gcactctggtgagactgccggtgacaaaccggaggaaggtggggatgacgtcaaatcatc 660
atgccccttatgacctgggctacacacgtgctacaatggatggtacaacgagttgcgaac 720atgccccttatgacctgggctacacacgtgctacaatggatggtacaacgagttgcgaac 720
tcgcgagagtaagctaatctcttaaagccattctcagttcggattgtaggctgcaactcg 780tcgcgagagtaagctaatctcttaaagccattctcagttcggattgtaggctgcaactcg 780
cctacatgaagtcggaatcgctagtaatcgcggatcagcatgccgcgggtgaatacgttc 840cctacatgaagtcggaatcgctagtaatcgcggatcagcatgccgcgggtgaatacgttc 840
ccgggccttgtacacaccgcccgtcacaccatgagagtttgtaacacccaaagtcggtgg 900ccgggccttgtacacaccgcccgtcacaccatgagagtttgtaacacccaaagtcggtgg 900
ggtaaccttttaggaaccagccgcctaaggtgggacagatgattagggtgaagtcgtaca 960ggtaaccttttaggaaccagccgcctaaggtgggacagatgattagggtgaagtcgtaca 960
ggggggaaccccttaaaatgttttttttttta 992ggggggaaccccttaaaatgttttttttttta 992
상기 락토바실러스 플란타럼 LAB459은 락토바실리 MRS 배지(Lactobacilli MRS broth) 또는 MRS 아가(MRS agar) 등과 같은 유산균 배양 배지에서 배양한 유산균의 균주를 통상적인 방법으로 순수 분리하여 에스쿨린(esculin)을 가수분해하는 β-글루코시다아제(β-glucosidase) 활성이 높은 균주일 수 있다.The Lactobacillus plantarum LAB459 is obtained by purely isolating a strain of a lactic acid bacterium cultured in a lactic acid bacteria culture medium such as Lactobacilli MRS broth or MRS agar by a conventional method to prepare esculin Glucosidase activity of the strain may be high.
본 발명에서는 락토바실러스(Lactobacillius)속 미생물을 옥수수수염 추출물에 접종한 후, 발효시켜 GABA의 함량이 높은 옥수수수염 발효물을 제조할 수 있다.In the present invention, a microorganism belonging to the genus Lactobacillus may be inoculated into a corn steep liquor and then fermented to produce a corn steep liquor having a high content of GABA.
일례로, 상기 락토바실러스(Lactobacillius)속 미생물로 락토바실러스 플란타럼 LAB459를 이용할 경우, 상기 락토바실러스 플란타럼 LAB459를 옥수수수염 추출물에 접종한 후, 30 내지 40 ℃의 온도에서 36 내지 120시간 동안 발효하여 옥수수수염 발효물을 제조할 수 있다. For example, when Lactobacillus plantarum LAB459 is used as a microorganism belonging to the genus Lactobacillus , the Lactobacillus plantarum LAB459 is inoculated into the cornstarch extract, and then incubated at a temperature of 30 to 40 DEG C for 36 to 120 hours Fermentation can be used to produce corn steep fermented products.
상기 발효시간이 36시간 미만인 경우, GABA의 생성량이 떨어지는 문제가 있을 수 있고, 120 시간을 초과하는 경우, 유산균의 수가 감소하는 문제가 있다. 바람직하게는 48 내지 72 시간 동안 발효하여 GABA를 다량 포함하는 옥수수수염 발효물을 제조할 수 있다.When the fermentation time is less than 36 hours, there may be a problem that the amount of GABA is lowered, and when the fermentation time exceeds 120 hours, the number of lactic acid bacteria is decreased. Preferably 48 to 72 hours, to produce a fermented corn steep state containing a large amount of GABA.
특히, 옥수수수염 2 중량%를 90 ℃ 이상으로 가열된 물에 첨가하여 30 내지 120분 이상 가열해 제조한 옥수수수염 열수 추출액에 상기 락토바실러스 플란타럼 LAB459 균주를 접종하고 37 ℃의 온도에서 72시간 동안 발효하여 제조한 옥수수수염 발효물은 GABA를 900 내지 1000 ppm/mL의 농도로 포함하여 GABA의 함량이 현저히 향상된 특성을 갖는다.In particular, 2% by weight of corn beard is added to water heated to 90 DEG C or more, and the mixture is heated for 30 to 120 minutes or more. The corn steep liquor is inoculated with the LAB459 strain at 37 DEG C for 72 hours , The fermented product of corn steep liquor containing GABA at a concentration of 900 to 1000 ppm / mL has a characteristic that the content of GABA is remarkably improved.
또한, 본 발명에서는 상기와 같이 제조한 옥수수수염 발효물을 감압 농축 등의 방법으로 농축하여 수분 함량이 더욱 낮은 반면에, GABA의 함량이 더욱 증진된 농축 옥수수수염 발효물을 제조할 수 있으며, 통상적인 발효물의 농축법이라면 제한받지 않고 사용할 수 있다.In addition, in the present invention, the fermented corn steep liquor prepared as described above can be concentrated by a method such as concentration under reduced pressure to produce a fermented corn steep liquor which has a lower moisture content, while further increasing the content of GABA, Any method of enrichment of the fermentation product can be used without limitation.
상기한 바와 같은 본 발명에 따른 옥수수수염 발효물의 제조방법에 따르면, 락토바실러스 플란타럼 LAB459을 옥수수수염 추출물에 접종 및 배양하여 감마-아미노부티르산의 함량이 높은 옥수수수염 발효물을 제조할 수 있다.According to the method for preparing the fermented corn steep liquor according to the present invention as described above, the fermented corn steep liquor having a high content of gamma-aminobutyric acid can be prepared by inoculating and culturing the LAB459 with LAB459.
또한, 본 발명은 상기에 기재된 방법을 이용해 제조한 옥수수수염 발효물을 포함하는 차, 젤리, 껌, 캔디 및 음료로 이루어진 군으로부터 선택되는 1종의 기능성 식품을 제공한다.The present invention also provides a functional food selected from the group consisting of tea, jelly, gum, candy, and beverages comprising the fermented corn steep state product prepared using the above-described method.
상기 기능성 식품은 분말, 과립, 정제, 캡슐 등과 같은 형태의 차, 젤리, 껌, 캔디, 음료, 비타민 복합제 등의 형태를 가질 수 있으며, 이에 한정하지 않는다. 상기 기능성 식품은 옥수수수염 발효물에 다량 포함된 GABA로 인해 각종 생리활성을 나타낼 수 있으며, 억제성 신경전달 기능을 나타내 혈압상승 억제, 시력증진, 진정 작용 등과 같은 다양한 생리활성을 나타낼 수 있다.The functional food may be in the form of tea, jelly, gum, candy, beverage, vitamin complex, etc. in the form of powders, granules, tablets, capsules and the like, but is not limited thereto. The functional food may exhibit various physiological activities due to GABA contained in a large amount of corn steep liquor fermented product, exhibits inhibitory neurotransmitter function, and exhibits various physiological activities such as inhibition of blood pressure increase, visual acuity enhancement, sedation and the like.
이때, 상기 기능성 식품은 상기 옥수수수염 발효물을 0.1 mg/mL 내지 10 mg/mL의 농도 혹은, 0.1 mg/g 내지 10 mg/g의 농도로 포함할 수 있으며, 상기 옥수수수염 발효물이 0.1 mg/mL 또는 0.1 mg/g 미만의 농도로 포함될 경우, 포함된 GABA 함량이 낮아 GABA에 의한 생리활성 효과를 기대하기 어려우며, 10 mg/mL 또는 10 mg/g을 초과하는 농도로 포함될 경우, 함유량 증가에 대한 효과 증대 정도가 미미하여 상기한 범위로 포함하도록 구성할 수 있다.At this time, the functional food may contain the fermented corn steep liquor at a concentration of 0.1 mg / mL to 10 mg / mL or a concentration of 0.1 mg / g to 10 mg / g, and the fermented corn steep liquor may contain 0.1 mg / mL or less than 0.1 mg / g, it is difficult to expect the effect of GABA on the physiological activity due to the low content of GABA, and when the concentration exceeds 10 mg / mL or 10 mg / g, So that it can be configured to be included in the range described above.
상기 기능성 식품은 상기 옥수수수염 발효물을 탄수화물, 영양제, 비타민, 무기질, 향미제, 착색제, 증진제, 펙트산, 알긴산, 구연산, 구연산 나트륨, 유기산, 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산화제 등을 추가로 혼합하여 차, 젤리, 껌, 캔디, 음료, 비타민 복합제 등의 형태로 제조될 수 있다.The functional food may be prepared by mixing the fermented corn steep liquor with at least one selected from the group consisting of carbohydrates, nutrients, vitamins, minerals, flavors, colorants, enhancers, pectic acids, alginic acid, citric acid, sodium citrate, organic acids, thickeners, pH adjusters, stabilizers, , A carbonating agent, and the like may be further mixed to prepare tea, jelly, gum, candy, beverage, vitamin complex, and the like.
구체적으로, 상기 향미제에는 천연 향미제인 타우마틴, 스테비아 추출물을 사용할 수 있으며, 합성 향미제인 사카린, 아스파르탐 등을 사용할 수 있다. 또한, 상기 탄수화물은 포도당, 과당, 말토스, 슈크로스, 덱스트린, 시클로덱스트린과 같은 사카라이드류, 자일리톨, 소르비톨, 에리트리톨 등의 당알코올을 사용할 수 있다. Specifically, natural flavors such as tau martin and stevia extract can be used as the flavor, and synthetic flavors such as saccharin and aspartame can be used. Examples of the carbohydrate include saccharides such as glucose, fructose, maltose, sucrose, dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol and erythritol.
상기 성분들은 제형 또는 사용 목적에 따라서 배합할 수 있으며, 그 첨가량은 본 발명의 목적 및 효과를 손상시키지 않는 범위 내로 포함될 수 있다. The above components may be blended according to the purpose of formulation or use, and the amount thereof may be included within a range that does not impair the objects and effects of the present invention.
이하, 본 발명을 실시예를 들어 더욱 상세히 설명하도록 한다.Hereinafter, the present invention will be described in more detail with reference to examples.
제시된 실시예는 본 발명의 구체적인 예시일 뿐이며, 본 발명의 범위를 제한하기 위한 것은 아니다.The embodiments presented are only a concrete example of the present invention and are not intended to limit the scope of the present invention.
<실시예><Examples>
(1) 옥수수수염 열수 추출물의 제조(1) Preparation of hot water extract of corn beard
옥수수 수염 2%(w/v)를 100 ℃의 열수에 첨가하고 1시간 동안 고압멸균기에서 반응시켜 옥수수수염의 열수 추출액을 제조하였다. 제조한 열수 추출액을 여과지에 통과시켜 1차 여과하고, 공극의 크기가 0.45 μm인 시린지 필터(syringe filter)로 2차 여과한 후, 2차 여과물을 제균하여 옥수수수염 열수 추출물을 제조하였다. 2% (w / v) of corn beard was added to hot water at 100 ° C and reacted in a high pressure sterilizer for 1 hour to prepare hot water extract of corn beard. The prepared hot-water extract solution was passed through a filter paper, subjected to primary filtration, secondary filtered with a syringe filter having a pore size of 0.45 μm, and secondary filtrate was sterilized to prepare a corn hog hydrothermal extract.
(2) 유산균의 분리 및 동정(2) Isolation and identification of lactic acid bacteria
유산균 균주를 분리하기 위해서, 0.05% L-시스테인(L-cystein)을 첨가하여 만든 락토바실리 MRS 배지(Lactobacilli MRS broth) 또는 MRS 아가(MRS agar)에 유산균을 접종하고, 37 ℃의 온도로 24 시간 동안 혐기성 조건에서 배양하였다. In order to isolate the lactic acid bacteria, Lactobacillus MRS broth or MRS agar prepared by adding 0.05% L-cysteine to the MRS agar was inoculated with the lactic acid bacteria and incubated at 37 ° C for 24 hours Lt; / RTI > under anaerobic conditions.
또한, 발효 식품 시료 25 g을 225 mL의 0.1% 펩톤수(peptone water)와 혼합하고, 균질화 처리 장치(stomacher)를 이용해 균질화한 후, 10진 희석을 하여 MRS 아가에 도말하고 37℃에서 48 내지 72 시간 동안 배양하였다. 배양을 통해 형성된 집락들 중 형태학적으로 상이한 집락을 선택하고, 이를 취해 MRS 아가에 평판 획선하여 접종하고, 선택한 집락의 유산균을 배양하여 순수 균주를 분리하였다. In addition, 25 g of the fermented food sample was mixed with 225 mL of 0.1% peptone water, homogenized using a stomacher, decalcified by decalculation, and spread on MRS agar. And cultured for 72 hours. The morphologically different colonies were selected from the colonies formed through the cultivation, picked up and inoculated in the MRS agar, and the pure strains were isolated by culturing the selected lactic acid bacteria.
균주가 갖는 β-글루코시다아제(β-glucosidase) 활성을 확인하기 위해 분리한 4종의 균주(0082, 0088, 0101 및 0459)를 각각 에스쿨린 아가(esculin agar)에 접종하였다. 그 후, 에스쿨린을 가수분해하여 배지를 흑갈색으로 변색시키는 능력이 가장 우수한 유산균 균주(459)를 β-glucosidase 생성 균주로 분리하였다(도 1 참조). Four strains (0082, 0088, 0101 and 0459) isolated from each other were inoculated into esculin agar in order to confirm the activity of the β-glucosidase of the strain. Thereafter, the lactic acid bacterial strain (459) having the best ability to hydrolyze esculin and discolor the medium to dark brown was isolated as a strain producing β-glucosidase (see FIG. 1).
분리한 β-glucosidase 생성 균주를 MRS 배지에 배양하고 배양액 1 mL을 취해 원심분리한 후 0.8% 멸균생리식염수로 수세하였다. 유전체 DNA 분석 키트(genomic DNA kit)를 사용하여 분리한 β-glucosidase 생성 균주의 DNA를 추출하였으며, 추출한 DNA를 PCR을 위한 주형 DNA(template DNA)로 사용하여 분리한 균주 각각의 16s rRNA 서열분석을 수행하였다. The isolated β-glucosidase-producing strains were cultured in MRS medium, centrifuged in 1 mL of the culture, and rinsed with 0.8% sterile physiological saline. The DNA of β-glucosidase-producing strains was isolated using a genomic DNA kit and the 16s rRNA sequence analysis of each of the strains isolated using the extracted DNA as the template DNA for PCR Respectively.
16s rRNA 서열분석을 위해, 세균의 16s rRNA에 대한 다용도 프라이머(universal primer)인 785F(GGATTAGATACCCTGGTA)와 907R(CCGTCAATTCMTTTRAGTTT)을 사용하여 PCR을 수행하였고, PCR을 수행한 후 전기영동을 통해 증폭산물을 확인하였으며, PCR 정제 키트(QIAquick PCR purification kit)를 사용하여 정제하였다.For 16s rRNA sequencing, PCR was performed using 785F (GGATTAGATACCCTGGTA) and 907R (CCGTCAATTCMTTTRAGTTT) universal primers for bacterial 16s rRNA, and amplification products were confirmed by electrophoresis after PCR And purified using a QIAquick PCR purification kit.
염기서열 분석용 키트(Dye Terminator Cycle Sequencing Ready Reaction Kit)와 서열분석기(ABI 3700 sequencer)를 이용해 분리한 β-glucosidase 생성 균주의 16S rRNA 염기서열 분석을 수행하였으며, PCR 수행시와 동일한 프라이머를 사용하였으며, 그 결과, 하기 서열번호 1과 같은 염기서열의 16S rRNA를 갖는다는 사실을 확인할 수 있었다.The 16S rRNA sequencing of β-glucosidase-producing strains was performed using a Dye Terminator Cycle Sequencing Ready Reaction Kit and an ABI 3700 sequencer. The same primers as in PCR were used As a result, it can be confirmed that it has the 16S rRNA of the base sequence shown in SEQ ID NO: 1 below.
[서열번호 1][SEQ ID NO: 1]
ggggggtaacgtgtcggattattgggcgtaagcgagcgcaggcggttttttaagtctgat 60gggggggtaacgtgtcggattattgggcgtaagcgagcgcaggcggttttttaagtctgat 60
gtgaaagccttcggctcaaccgaagaagtgcatcggaaactgggaaacttgagtgcagaa 120gtgaaagccttcggctcaaccgaagaagtgcatcggaaactgggaaacttgagtgcagaa 120
gaggacagtggaactccatgtgtagcggtgaaatgcgtagatatatggaagaacaccagt 180gaggacagtggaactccatgtgtagcggtgaaatgcgtagatatatggaagaacaccagt 180
ggcgaaggcggctgtctggtctgtaactgacgctgaggctcgaaagtatgggtagcaaac 240ggcgaaggcggctgtctggtctgtaactgacgctgaggctcgaaagtatgggtagcaaac 240
aggattagataccctggtagtccataccgtaaacgatgaatgctaagtgttggagggttt 300aggattagataccctggtagtccataccgtaaacgatgaatgctaagtgttggagggttt 300
ccgcccttcagtgctgcagctaacgcattaagcattccgcctggggagtacggccgcaag 360ccgcccttcagtgctgcagctaacgcattaagcattccgcctggggagtacggccgcaag 360
gctgaaactcaaaggaattgacgggggcccgcacaagcggtggagcatgtggtttaattc 420gctgaaactcaaaggaattgacgggggcccgcacaagcggtggagcatgtggtttaattc 420
gaagctacgcgaagaaccttaccaggtcttgacatactatgcaaatctaagagattagac 480gaagctacgcgaagaaccttaccaggtcttgacatactatgcaaatctaagagattagac 480
gttcccttcggggacatggatacaggtggtgcatggttgtcgtcagctcgtgtcgtgaga 540gttcccttcggggacatggatacaggtggtgcatggttgtcgtcagctcgtgtcgtgaga 540
tgttgggttaagtcccgcaacgagcgcaacccttattatcagttgccagcattaagttgg 600
gcactctggtgagactgccggtgacaaaccggaggaaggtggggatgacgtcaaatcatc 660gcactctggtgagactgccggtgacaaaccggaggaaggtggggatgacgtcaaatcatc 660
atgccccttatgacctgggctacacacgtgctacaatggatggtacaacgagttgcgaac 720atgccccttatgacctgggctacacacgtgctacaatggatggtacaacgagttgcgaac 720
tcgcgagagtaagctaatctcttaaagccattctcagttcggattgtaggctgcaactcg 780tcgcgagagtaagctaatctcttaaagccattctcagttcggattgtaggctgcaactcg 780
cctacatgaagtcggaatcgctagtaatcgcggatcagcatgccgcgggtgaatacgttc 840cctacatgaagtcggaatcgctagtaatcgcggatcagcatgccgcgggtgaatacgttc 840
ccgggccttgtacacaccgcccgtcacaccatgagagtttgtaacacccaaagtcggtgg 900ccgggccttgtacacaccgcccgtcacaccatgagagtttgtaacacccaaagtcggtgg 900
ggtaaccttttaggaaccagccgcctaaggtgggacagatgattagggtgaagtcgtaca 960ggtaaccttttaggaaccagccgcctaaggtgggacagatgattagggtgaagtcgtaca 960
ggggggaaccccttaaaatgttttttttttta 992ggggggaaccccttaaaatgttttttttttta 992
또한, 16S rRNA 염기서열의 상동성(homologous)의 분석은 미국 국립생물공학정보센터(National Center for Biotechnology Information, NCBI)의 BLAST 검색 프로그램(Basic local alignment search tool, BLAST)을 이용하여 DNA 데이터베이스와 비교하는 방법으로 수행하였으며, 그 결과를 하기의 표 1에 나타내었다. In addition, the analysis of homologous sequences of 16S rRNA sequences was performed using the BLAST search program (BLAST) of the National Center for Biotechnology Information (NCBI) The results are shown in Table 1 below.
또한, β-glucosidase 생성 균주(유산균 LAB459)의 16S rRNA 염기서열의 계통학적 분석(Clustal X, BioEdit, MEGA 4)을 수행하여 염기서열간의 유전적 거리와 계통수(phylogenetic tree)를 확인하였으며, 그 결과를 도 2에 나타내었다.In addition, phylogenetic analysis (Clustal X, BioEdit, MEGA 4) of the 16S rRNA sequence of β-glucosidase producing strain (LAB459) confirmed the genetic distance and phylogenetic tree between the nucleotide sequences, Is shown in Fig.
상기와 같이 β-glucosidase 생성 균주의 16S rRNA 염기서열, 상동성 및 계통수 분석 결과를 통해 상기 균주를 락토바실러스 플란타럼 LAB459(Lactobacillus plantarum LAB459)으로 명명하였다.As described above, the strain was named LAB459 ( Lactobacillus plantarum LAB459) through the 16S rRNA nucleotide sequence, homology and phylogenetic analysis results of the strain producing β-glucosidase.
(3) 옥수수수염 발효물의 제조(3) Preparation of fermented corn beard
분리한 LAB459 균주의 배양액을 원심분리한 후, 침전물을 멸균수로 세척하고, 세척한 균주를 취해 스킴 밀크 5 부피%, 글루탐산모노나트륨(monosodium glutamate) 3 부피% 및 나머지 제조한 옥수수수염 열수 추출물을 포함하는 혼합액에 접종하였으며, 37 ℃의 온도에서 각각 12 내지 72시간 동안 배양하여 시간별 옥수수수염 발효 배양액을 제조하였다.The culture of the isolated LAB459 strain was centrifuged, and the precipitate was washed with sterilized water. The washed strain was taken, 5 volume% of skim milk, 3 volume% of monosodium glutamate, and the remaining corn steep liquor hydrothermal extract And cultured at 37 ° C for 12 to 72 hours, respectively, to prepare a fermentation broth of corn steep liquor over time.
제조한 옥수수수염 발효 배양액을 취해 8,000 rpm의 속도로 10분 동안 원심분리하여 상등액을 수득하였으며, 수득한 상등액을 시린지 필터로 여과 및 제균하여 옥수수수염 발효물을 제조하였다.The prepared corn steep fermentation broth was taken and centrifuged at a speed of 8,000 rpm for 10 minutes to obtain a supernatant. The resulting supernatant was filtered and sterilized by a syringe filter to prepare a corn steep fermented product.
<실험예> 분리한 균주의 GABA 생성 능력 분석<Experimental Example> Analysis of GABA production ability of isolated strains
(1) HPLC 분석(1) HPLC analysis
LAB459 균주의 GABA 생성 능력을 분석하기 위해서, 하기에 나타낸 바와 같은 HPLC 조건으로 고속액체 크로마토그래피(high performance liquid chromatography, HPLC)를 수행하였으며, 그 결과를 도 3에 나타내었고, 표 2에 나타낸 바와 같이 이동상 A 및 이동상 B를 전개하였다. In order to analyze GABA production ability of LAB459 strain, high performance liquid chromatography (HPLC) was performed under HPLC conditions as shown below. The results are shown in FIG. 3, and as shown in Table 2 Mobile phase A and mobile phase B were developed.
[HPLC 조건][HPLC conditions]
컬럼(Column) : Agilent HC-C18(2) reverse phase ColumnColumn: Agilent HC-C18 (2) reverse phase Column
컬럼 온도(Column temperature) : 40 ℃Column temperature: 40 캜
유속(Flow rate) : 1.5 mL/분 Flow rate: 1.5 mL / min
HPLC 검출 파장(Wave length) : 358 nm HPLC detection Wave length: 358 nm
주입량(injection volume) : 10 μLInjection volume: 10 μL
이동상 - A : 40 mM 인산수소이나트륨(sodium phosphate dibasic) 및 0.1% 인산(phosphoric acid)을 포함하는 혼합물 사용Mobile phase - A: Mixture containing 40 mM sodium phosphate dibasic and 0.1% phosphoric acid
이동상 - B : 아세토니트릴(acetonitrile), 메탄올 및 물을 45 : 45 : 10의 부피비로 포함하는 혼합물 사용Mobile phase - B: Mixture containing acetonitrile, methanol and water in a volume ratio of 45: 45: 10
도 3(a)의 옥수수수염 발효물에 생성된 GABA를 검출하기 위해 280 nm 파장으로 검출한 GABA의 표준물질 피크(280 nm)와 비교하여 LAB459 균주를 이용한 발효를 통해 옥수수수염 발효물에 생성된 GABA를 검출한 결과, 도 3(b)에 나타난 바와 같이, 제조한 옥수수수염 발효물에서 GABA의 피크가 확인되어 옥수수수염 발효물에 GABA가 생성되어 있음을 확인할 수 있었다.In order to detect the GABA produced in the corn steep liquor fermentation of Fig. 3 (a), the fermentation using the LAB459 strain was compared with the peak of the GABA standard (280 nm) detected at a wavelength of 280 nm, As a result of the detection of GABA, as shown in FIG. 3 (b), the peak of GABA was confirmed in the fermented corn steep so that GABA was produced in the fermented corn steep.
(2) TLC 분석(정성분석)(2) TLC analysis (qualitative analysis)
분리한 LAB459 균주의 GABA 생성 능력을 분석하기 위해서, 12 내지 72시간 동안 발효하여 제조한 옥수수수염 발효물 각각을 취해 박막 크로마토그래피 판[thin-layer chromatography(TLC) plate]에 분주하고, 부탄올(butanol), 아세트산(acetic acid) 및 증류수(water)를 각각 4 : 1 : 1의 부피비로 포함하는 혼합물을 전개용매로 사용하여 전개하였으며, 옥수수수염 발효 배양액이 전개된 TLC 판에 0.2%의 닌하이드린(ninhydrin)을 공급해 발색 반응을 유도해 생성된 GABA 스팟과 기질인 글루탐산의 스팟을 확인하는 방법으로 분리한 β-glucosidase 생성 균주가 갖는 GABA 생성 능력을 확인하였으며, 그 결과를 도 4에 나타내었다. 참고로, 도 4의 TLC 분석은 12, 18, 24, 30, 36, 42, 48, 54, 60, 66 및 72시간 동안 발효하여 제조한 옥수수수염 각각의 GABA 스팟 및 글루탐산 스팟을 나타낸다.In order to analyze the ability of LAB459 to produce GABA, each of the fermented corn steep liquor prepared by fermentation for 12 to 72 hours was divided into thin-layer chromatography (TLC) plate, ), Acetic acid and distilled water at a volume ratio of 4: 1: 1 were developed as a developing solvent. To the TLC plate in which the fermentation broth of the corn steep liquor was developed, 0.2% of ninhydrin (ninhydrin) to induce the color-development reaction, and the GABA spot produced and the spot of the glutamic acid as the substrate were identified. The result was shown in FIG. 4, which shows the ability of the strain producing β-glucosidase to be isolated. For reference, the TLC analysis of FIG. 4 shows GABA spots and glutamate spots of each of the corn beets prepared by fermentation for 12, 18, 24, 30, 36, 42, 48, 54, 60, 66 and 72 hours.
도 4에 나타난 바와 같이, 분리한 LAB459 균주는 48시간 이상 발효한 시점에서부터 GABA의 함량이 서서히 증가하여 72시간 발효한 경우에는 GABA 스팟이 더욱 진해져 GABA의 함량이 현저히 증가하였다는 사실을 확인할 수 있다.As shown in FIG. 4, the isolated LAB459 strain showed a gradual increase in the content of GABA from the fermentation time of 48 hours or more, and when the fermentation was conducted for 72 hours, the GABA spot became more dense and the content of GABA was remarkably increased .
(3) Gabase 분석(정량분석)(3) Gabase analysis (quantitative analysis)
또한, 72시간 동안 발효하여 제조한 옥수수수염 발효물에 포함된 GABA의 함량을 Gabase와 GABA의 효소 반응을 이용한 Gabase 분석법을 이용하여 정량분석 하였다. The content of GABA contained in the fermented corn steep liquor fermented for 72 hours was quantitatively analyzed by Gabase analysis using the enzyme reaction of gabase and GABA.
그 결과, 72시간 동안 발효하여 제조한 옥수수수염 발효물에 포함된 GABA의 함량이 992 ppm/mL의 농도로 포함되어 있다는 사실을 확인할 수 있었으며, 이를 통해, 분리한 LAB459 균주로 옥수수수염 열수 추출물을 발효할 경우, GABA의 함량이 현저히 높은 옥수수수염의 발효물을 제조할 수 있음을 확인할 수 있었다.As a result, it was confirmed that the content of GABA contained in the corn steep liquor fermented by fermentation for 72 hours was contained at a concentration of 992 ppm / mL. As a result, it was confirmed that the corn steep liquor hydrothermal extract When the fermentation was carried out, it was confirmed that a fermented product of corn bean having a remarkably high GABA content could be produced.
Claims (5)
상기 락토바실러스(Lactobacillius)속 미생물은 서열번호 1로 표시되는 16s rRNA를 포함하는 락토바실러스 플란타럼 LAB459(Lactobacillus plantarum LAB459)인 것을 특징으로 하는 옥수수수염 발효물의 제조방법.The method according to claim 1,
Wherein the microorganism belonging to the genus Lactobacillus is Lactobacillus plantarum LAB459 comprising 16s rRNA represented by SEQ ID NO: 1.
상기 락토바실러스 플란타럼 LAB459를 옥수수수염 추출물에 접종한 후, 36 내지 72시간 동안 배양하는 것을 특징으로 하는 옥수수수염 발효물의 제조방법. 3. The method of claim 2,
Wherein the lactobacillus plantarum LAB459 is inoculated to the corn beard extract and then cultured for 36 to 72 hours.
상기 락토바실러스 플란타럼 LAB459을 접종하여 제조한 옥수수수염 발효물은 감마-아미노부티르산을 900 내지 1000 ppm/mL의 농도로 포함하는 것을 특징으로 하는 옥수수수염 발효물의 제조방법. The method according to claim 1,
Wherein the fermented corn steep lobate prepared by inoculating the lactobacillus plantarum LAB459 contains gamma-aminobutyric acid at a concentration of 900 to 1000 ppm / mL.
A functional food selected from the group consisting of tea, jelly, gum, candies and beverages comprising corn steep fermented product prepared using the method of any one of claims 1 to 4.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160138537A KR20180044706A (en) | 2016-10-24 | 2016-10-24 | Method for preparing corn silk fermentation product enhanced gamma-aminobutyric acid contents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160138537A KR20180044706A (en) | 2016-10-24 | 2016-10-24 | Method for preparing corn silk fermentation product enhanced gamma-aminobutyric acid contents |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20180044706A true KR20180044706A (en) | 2018-05-03 |
Family
ID=62244642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160138537A KR20180044706A (en) | 2016-10-24 | 2016-10-24 | Method for preparing corn silk fermentation product enhanced gamma-aminobutyric acid contents |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20180044706A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113332387A (en) * | 2021-04-27 | 2021-09-03 | 浙江中医药大学 | Corn silk fermentation method |
-
2016
- 2016-10-24 KR KR1020160138537A patent/KR20180044706A/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113332387A (en) * | 2021-04-27 | 2021-09-03 | 浙江中医药大学 | Corn silk fermentation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101402031B1 (en) | Method for producing fermented herb extract with high GABA content using Lactobacillus plantarum K154 | |
KR101753077B1 (en) | A method for preparing fermented ginseng extract and compositions comprising thereof | |
KR101343410B1 (en) | Novel Lactobacillus plantarum CRNB-22 (KCTC 11931 BP) strain capable of fermenting ginseng and method of transforming saponin using thereof | |
JP4693487B2 (en) | Method for producing lactic acid bacteria and tea beverage | |
KR20180032231A (en) | Novle Lactobacillus plantarum SI-6 and Lactobacillus rhamnosus SI-15 strain, and uses thereof | |
KR20070016253A (en) | 1-deoxynojirimycin-producing bacillus subtilis s10 strain and composition comprising same | |
KR20130107940A (en) | Method of producing fermented red ginseng | |
KR101413263B1 (en) | Bacillus amyloliquefaciens 26N producing 1-Deoxynojirimycin and method for producing fermented soybean having anti-diabetic activity using thereof | |
KR101464546B1 (en) | Debaryomyces hansenii having high productivity of gamma-aminobutyric acid from traditionally fermented soybean products, and uses thereof | |
JP5904522B2 (en) | Microorganisms producing azasugar | |
KR20180044706A (en) | Method for preparing corn silk fermentation product enhanced gamma-aminobutyric acid contents | |
González et al. | Tannases | |
KR100631857B1 (en) | -3 Lactobacillus Brevis OPK-3 Having a High Production Ability of Gamma-Aminobutyric Acid | |
KR101407231B1 (en) | Method for producing fermented herb extract with high GABA content using Lactobacillus helveticus RMK85 | |
KR101063624B1 (en) | Schizandra fermented product, fermentation method thereof and food composition comprising the fermented product | |
KR102243418B1 (en) | Novel acetic acid bacteria and process for preparing Kombucha beverages using the same | |
CN112538439B (en) | Lactobacillus plantarum and application thereof in preparing plant coagulated yoghurt and improving intestinal bacterial facies | |
TWI689593B (en) | Method for preparing high-yield γ-aminobutyric acid | |
KR101413268B1 (en) | Bacillus amyloliquefaciens 335N producing 1-Deoxynojirimycin and method for producing fermented soybean having anti-diabetic activity using thereof | |
KR101343434B1 (en) | Novel Enterococcus faecalis CRNB-A3 (KCTC 11930 BP) strain capable of fermenting ginseng and method of transforming saponin using thereof | |
KR20200059773A (en) | Method of preparing fermented product of mulberry leaves with enhanced GABA component and food composition comprising the fermented product thereby | |
KR101608271B1 (en) | A strain of rhizopus stolonifer from fermented tea and uses thereof | |
KR101069686B1 (en) | A NOVEL Phellinus sp. STRAIN AND POLYSACCHARIDE THEREFROM HAVING ANTITUMOR AND IMMUNE ACTIVITY | |
KR101608272B1 (en) | A strain of penicillium citrinum from fermented tea and uses thereof | |
JP6370058B2 (en) | Method for producing rubusoside |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E601 | Decision to refuse application |